NT100

DRUG2 trials

Sponsors

Nora Therapeutics, Inc.

Conditions

Recurrent MiscarriageRecurrent Pregnancy LossRepeated IVF Failure

Phase 2

A Multi-Center Study To Evaluate Multiple Doses of NT100 Following IVF In Women With Repeated IVF Failures (Thrive-IVF)

CompletedNCT01864356

Nora Therapeutics, Inc.Repeated IVF Failure

Start: 2013-05-31End: 2014-09-30Updated: 2014-11-20

A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL)

Nora Therapeutics, Inc.Recurrent Miscarriage, Recurrent Pregnancy Loss

Start: 2014-06-30End: 2016-06-30Target: 150Updated: 2015-07-15

Related Papers

Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.

2019-03-0133 citations